guillain barre syndrome (gbs) is an inflammatory, usually demyelinating, polyneuropathy; clinically characterized by acute onset of symmetric progressive muscle weakness with loss of myotatic reflexes. thirty five patients with gbs, defined clinically according to the criteria of asbury and cornblath, were recruited from three hospital affiliated to tehran university of medical sciences.as a co...

BACKGROUND Although infection with Campylobacter jejuni is recognized as a common antecedent of the Guillain-Barré syndrome, the clinical and epidemiologic features of this association are not well understood. METHODS We performed a prospective case-control study in a cohort of patients with Guillain-Barré syndrome (96 patients) or Miller Fisher syndrome (7 patients) who were admitted to hosp...

Objective: To determine the frequency of axonal variants in our patients of Guillain-Barre Syndrome. Study Design: Descriptive study. Place and Duration: Department of Neurology, Military Hospital, Rawalpindi and Armed Forces Institute of Rehabilitation Medicine (AFIRM) from 01 Jan 2009 to 30 Jul 2010. Patients and Methods: Forty adult patients meeting the National Institute of Neurological Dis...

Guillain-Barré syndrome and acute transverse myelitis manifest as demyelinating diseases of the peripheral and central nervous system. Concurrency of these two disorders is rarely documented in literature. A 4-year-old girl presenting with cough, fever, and an impaired walking ability was admitted to hospital. She had no previous complaints in her medical history. A physical examination reveale...

Multiple cranial nerve dysfunction can occur with primary intracranial processes (neoplasm, basilarvertebral insufficiency, congenital defects, aneurysms, dural vein thrombosis, multiple sclerosis), myopathy or neuromuscular junction disorder (myasthenia gravis, botulism, orbital 'myositis', ocular myopathy), and as a manifestation of a more systemic disorder (sarcoidosis, endocrinopathy, conne...

INTRODUCTION Guillain-Barre syndrome, or acute inflammatory demyelinating polyneuropathy, has been described in the presence of malignancies such as lymphoma. Guillain-Barre syndrome/acute inflammatory demyelinating polyneuropathy causes paresthesias and weakness, which can make the treatment of lymphoma with chemotherapy challenging. Given the rarity of this co-presentation it is not known if ...

OBJECTIVE To report a case of severe Guillain-Barré syndrome in a 32-year old female patient diagnosed with acute lymphoblastic leukaemia who was on chemotherapy. CLINICAL PRESENTATION AND INTERVENTION The patient received chemotherapy including vincristine and steroids according to the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia-12 (MRC UKALL-12) protocol. On the 21...

BACKGROUND Miller Fisher Syndrome is characterized by the clinical triad of ophthalmoplegia, ataxia, and areflexia, and is considered to be a variant of Guillain-Barre Syndrome. Miller Fisher Syndrome is observed in approximately 1-5% of all Guillain-Barre cases in Western countries. Patients with Miller Fisher Syndrome usually have good recovery without residual deficits. Venous thromboembolis...

OBJECTIVE To delineate the possible implication of the immunosuppressive cytokine transforming growth factor beta 1 (TGF-beta1) in the pathogenesis of Guillain-Barré syndrome. Guillain-Barré syndrome is a disorder that may implicate cytokines in its pathogenesis. TGF-beta1 is a potent anti-inflammatory cytokine occasionally shown to be regulated in the course of demyelinating disorders. METHO...

OBJECTIVE The aim of this report is to highlight the importance of close observation and follow-up in children who present with an acutely irritable hip. This is because hip pain is a symptom of not only benign but also severe conditions. Thus, at the time of the initial presentation, hip pain can be misdiagnosed. This report serves as an example for a wide range of doctors such as orthopaedic ...